Antisense oligonucleotides reverse rare neurodevelopmental disorder in preclinical models
Lucian Nemoiu
St. Jude Children's Research Hospital Apr 22 2026 Scientists at St. Jude Children's Research Hospital have found they can reverse the effects of HNRNPH2 -related neurodevelopmental disorder using antisense oligonucleotides (ASOs) in preclinical models. ASOs are short synthetic nucleic acid strands that target specific messenger RNA. Published in Science Translational Medicine , the researchers showed that ASOs block production of the aberrant HNRNPH2 protein. This consequently boosts
din zilele anterioare